SMTL ID : 8fxq.1 (1 other biounit)

The Crystal Sturucture of Rhizopuspepsin with a bound modified peptide inhibitor generated by de novo drug design.

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.21 Å

Oligo State

monomer

Ligands

1 x ALA- CYS- VAL- LYS: ALA-CYS-VAL-LYS(Non-covalent)

ALA-CYS-VAL-LYS.1: 17 residues within 4Å: Chain A: I.19, D.37, D.39, G.41, Y.81, G.82, D.83, S.85, F.118, L.126, D.222, G.224, T.225, T.226, I.229, I.302 Ligands: CHX.2 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:Y.81, A:Y.81, A:D.83, A:L.126, A:I.229, A:I.302 Hydrogen bonds: A:G.82, A:D.83, A:D.83, A:T.225, A:T.226, A:T.226 Water bridges: A:D.37, A:S.85, A:S.85, A:L.227

1 x CHX: CYCLOHEXANE(Non-covalent)

CHX.2: 5 residues within 4Å: Chain A: E.20, D.83, N.123 Ligands: ALA-CYS-VAL-LYS.1, ALA-CYS-VAL-LYS.1 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ripka, A.S. et al., Aspartic protease inhibitors designed from computer-generated templates bind as predicted. Org Lett (2001)

Release Date

2023-02-08

Peptides

Rhizopuspepsin: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Rhizopuspepsin

Related Entries With Identical Sequence